APG Asset Management US Inc. Reduces Position in Humana Inc. (NYSE:HUM)

APG Asset Management US Inc. lessened its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 57.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,488 shares of the insurance provider's stock after selling 3,301 shares during the period. APG Asset Management US Inc.'s holdings in Humana were worth $631,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of HUM. Vanguard Group Inc. raised its position in shares of Humana by 15.8% in the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after buying an additional 1,751,857 shares in the last quarter. Norges Bank bought a new position in shares of Humana in the fourth quarter worth approximately $416,202,000. Pzena Investment Management LLC raised its stake in Humana by 44.0% in the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after purchasing an additional 1,103,132 shares in the last quarter. Boston Partners lifted its position in Humana by 435.8% during the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock valued at $279,236,000 after purchasing an additional 893,637 shares during the last quarter. Finally, Invesco Ltd. raised its position in shares of Humana by 29.8% during the 4th quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock valued at $608,348,000 after buying an additional 550,692 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Truist Financial raised their price target on Humana from $290.00 to $325.00 and gave the company a "hold" rating in a research report on Friday. Mizuho upped their price objective on shares of Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Guggenheim initiated coverage on Humana in a research note on Wednesday, April 9th. They set a "buy" rating and a $326.00 price objective for the company. StockNews.com upgraded shares of Humana from a "hold" rating to a "buy" rating in a research report on Monday, April 7th. Finally, Robert W. Baird raised their target price on Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research note on Tuesday. Seventeen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $284.90.

Humana Stock Up 0.1 %

HUM stock traded up $0.16 on Tuesday, reaching $284.98. 360,440 shares of the company traded hands, compared to its average volume of 1,745,740. The firm has a fifty day simple moving average of $265.43 and a 200-day simple moving average of $270.11. The company has a market cap of $34.40 billion, a P/E ratio of 28.64, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.24%. Humana's payout ratio is 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.